Chemoinformaics analysis of (1R)-deacetylipecoside
| Molecular Weight | 524.543 | nRot | 7 |
| Heavy Atom Molecular Weight | 490.271 | nRig | 25 |
| Exact Molecular Weight | 524.213 | nRing | 4 |
| Solubility: LogS | -1.877 | nHRing | 3 |
| Solubility: LogP | -0.891 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 6 |
| nHA | 11 | APOL | 74.343 |
| nHD | 7 | BPOL | 41.921 |
| QED | 0.136 |
| Synth | 4.961 |
| Natural Product Likeliness | 2.486 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.989 |
| HIA | 0.954 |
| CACO-2 | -6.266 |
| MDCK | 0.0000435 |
| BBB | 0.161 |
| PPB | 0.450339 |
| VDSS | 0.852 |
| FU | 0.595402 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.087 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.174 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.2 |
| CYP3a4-inh | 0.035 |
| CYP3a4-sub | 0.194 |
| CL | 1.734 |
| T12 | 0.873 |
| hERG | 0.162 |
| Ames | 0.631 |
| ROA | 0.18 |
| SkinSen | 0.281 |
| Carcinogencity | 0.195 |
| EI | 0.011 |
| Respiratory | 0.855 |
| NR-Aromatase | 0.056 |
| Antiviral | Yes |
| Prediction | 0.783488 |